TI
BIIB icon

tru Independence’s Biogen BIIB Stock Holding History

tru Independence’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-119
Closed -$41K – 206
2021
Q2 		$41K Buy
+119
New +$36K 0.01% 232
2021
Q1 		– Sell
-94
Closed -$23 – 337
2020
Q4 		$23 Buy
94
+4
+4% +$1.03K ﹤0.01% 532
2020
Q3 		$26K Hold
90
– – 0.01% 238
2020
Q2 		$24K Hold
90
– – ﹤0.01% 479
2020
Q1 		$28K Hold
90
– – ﹤0.01% 349
2019
Q4 		$28K Buy
+90
New +$25K ﹤0.01% 438

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

tru Independence's BIIB Position: Q3 2021 in Review

tru Independence sold out of Biogen (BIIB) in Q3 2021, closing a stake of 119 shares — an estimated $41K sold.

tru Independence first reported a position in BIIB in Q4 2019 and held it in 6 quarters. The position peaked at $41K in Q2 2021. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • tru Independence reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
  • tru Independence sold 119 Biogen shares in Q3 2021, an estimated $41K.
  • tru Independence first reported a position in Biogen in Q4 2019 and held it in 6 quarters.
  • tru Independence's Biogen position peaked at $41K in Q2 2021.
  • 1,041 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on tru Independence's 13F filing for Q3 2021, filed 12 Nov 2021.